当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析 - 现金流量表

灵康药业

(603669)

  

流通市值:36.97亿  总市值:36.97亿
流通股本:7.12亿   总股本:7.12亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金309,192,099.43246,221,143.6469,321,072.75371,605,687.42
  收到其他与经营活动有关的现金16,269,231.1412,321,428.974,643,390.2531,529,453.64
  经营活动现金流入小计325,461,330.57258,542,572.6173,964,463403,135,141.06
  购买商品、接受劳务支付的现金190,406,531.12175,780,726.6355,829,571.63255,757,641.14
  支付给职工以及为职工支付的现金26,332,064.9119,448,777.2511,397,042.844,884,098.31
  支付的各项税费17,950,812.119,401,358.086,566,882.2515,241,611.72
  支付其他与经营活动有关的现金115,476,243.7168,113,107.329,404,665.42220,116,875.65
  经营活动现金流出小计350,165,651.85272,743,969.26103,198,162.1536,000,226.82
  经营活动产生的现金流量净额-24,704,321.28-14,201,396.65-29,233,699.1-132,865,085.76
二、投资活动产生的现金流量:
  收回投资收到的现金---9,697,845.18
  取得投资收益收到的现金---1,105,526.31
  处置固定资产、无形资产和其他长期资产收回的现金净额100,000100,000100,0007,008,973.97
  收到的其他与投资活动有关的现金5,611,290.575,000,000-17,332,762
  投资活动现金流入小计5,711,290.575,100,000100,00035,145,107.46
  购建固定资产、无形资产和其他长期资产支付的现金2,205,556.232,030,506.231,921,1602,683,196.08
  投资活动现金流出小计2,205,556.232,030,506.231,921,1602,683,196.08
  投资活动产生的现金流量净额3,505,734.343,069,493.77-1,821,16032,461,911.38
三、筹资活动产生的现金流量:
  取得借款收到的现金25,000,00020,000,00020,000,00015,000,000
  收到其他与筹资活动有关的现金386,001,713.45386,001,713.451,713.45250,000,000
  筹资活动现金流入小计411,001,713.45406,001,713.4520,001,713.45265,000,000
  偿还债务支付的现金1,000,0001,000,000--
  分配股利、利润或偿付利息支付的现金474,113.26298,555.58130,722.236,591,341.08
  支付其他与筹资活动有关的现金391,000,000386,000,000-252,067,443.33
  筹资活动现金流出小计392,474,113.26387,298,555.58130,722.23258,658,784.41
  筹资活动产生的现金流量净额18,527,600.1918,703,157.8719,870,991.226,341,215.59
五、现金及现金等价物净增加额-2,670,986.757,571,254.99-11,183,867.88-94,061,958.79
  加:期初现金及现金等价物余额153,207,461.73153,207,461.73153,207,461.73247,269,420.52
  期末现金及现金等价物余额150,536,474.98160,778,716.72142,023,593.85153,207,461.73
补充资料:
  净利润-21,112,693.34--193,239,351.39
  资产减值准备-87,913.95-41,449,843.73
  固定资产和投资性房地产折旧-11,302,114.27-23,805,420.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,302,114.27-23,805,420.43
  无形资产摊销-3,532,107.67-7,260,712.26
  长期待摊费用摊销-1,370,214.06-3,505,953.31
  处置固定资产、无形资产和其他长期资产的损失--82,662.06--3,533,141.93
  固定资产报废损失-1,959.29-818,869.01
  公允价值变动损失-4,012,230.84-570,782.06
  财务费用-10,949,533.78-21,197,524.07
  投资损失-505,778.54-2,407,842.88
  递延所得税--232,533.64--465,067.31
    递延所得税负债增加--232,533.64--465,067.31
  存货的减少-8,127,747.81--59,641,231.71
  经营性应收项目的减少--48,780,015.93-6,317,605.54
  经营性应付项目的增加--33,582,196.07--26,007,310.57
  其他--112,311.82-41,741,183.73
  现金的期末余额-160,778,716.72-153,207,461.73
  减:现金的期初余额-153,207,461.73-247,269,420.52
  现金及现金等价物的净增加额-7,571,254.99--94,061,958.79
公告日期2026-10-242026-08-152026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑